MEDTRONIC DIABETES

332 Riverchase Blvd, Crestview, Florida, United States

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

81.2%

Phase 4

4.3%

Phase 3

2.9%

Trial Status Distribution

Active, not recruiting

1.4%

Completed

87.0%

Not yet recruiting

2.9%

Terminated

1.4%

Withdrawn

7.3%

Clinical Trials

Trials sponsored by this organization (69)

SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes

Not Applicable

Withdrawn

interventional

May 20251,500 participants

Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Not Applicable

Completed

interventional

May 2022244 participants

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Not Applicable

Completed

interventional

Mar 2022240 participants

Page 1 of 9

Approvals

No approval data available

News

No news articles found

Back to Organizations

MEDTRONIC DIABETES

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (69)

SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes

Smart MDI Study (CIP343)

Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children

InPen User Experience

Evaluation of the MiniMed 780 System in Paediatric Subjects

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Approvals

News